What Recent Federal Vaccine Recommendation Changes Could Mean for No-Cost Coverage and Access in 2026
Federal vaccine recommendation wording can shape no-cost coverage. Here’s how private plans, Medicaid, Medicare, and VFC may differ in 2026.
Federal vaccine recommendation wording can shape no-cost coverage. Here’s how private plans, Medicaid, Medicare, and VFC may differ in 2026.
Measles cases are climbing. Here’s when babies 6 to 11 months may get an early MMR shot, why it does not replace routine doses, and what parents should do.
A new JAMA Internal Medicine estimate puts CT scan safety back in focus. Here’s what the model found, what it did not prove, and what to ask before imaging.
The FDA says phone settings or software problems can disrupt diabetes device alerts, raising the risk of missed low blood sugar warnings and delayed treatment.
A randomized trial in community health centers found that team-based support plus home blood pressure checks improved systolic pressure more than enhanced usual care.
CMS says it began enforcing updated hospital price transparency rules on April 1, 2026, but patients should still treat posted prices as a starting point.
Diabetes can raise the risk of bleeding gums, dry mouth, infection, and slower healing. Here’s how to spot trouble early and protect your mouth every day.
Updated CDC pages show fall deaths are still rising in older adults. Here’s how fall prevention, bone health, screening, and Medicare coverage connect.
A new U.S. cholesterol guideline adds more emphasis to one-time lipoprotein(a) testing. Here’s who may want to ask and what the result can mean.
Original Medicare can pay for some hearing tests in 2026, but hearing aids are still usually excluded. Here is what changed, what did not, and what to compare.
A bigger physician pipeline is good news, but U.S. patients may still face waits and access problems as primary care, nursing, and public health shortages persist.
As of April 1, 2026, CMS is enforcing updated hospital price transparency rules. The files may be easier to compare, but they still are not your final bill.
Medicaid work requirements are edging closer, and the biggest risk may be paperwork. Here is what enrollees should do now to protect coverage before 2027.
CMS is proposing faster, more electronic drug prior authorization rules, but patients should know the policy is not final and current public data still leave big gaps.
CDC says U.S. measles activity is elevated in 2026, but risk is not equal everywhere. Here’s what symptoms, exposure timing, and MMR protection mean.
A CMS proposal could eventually speed some drug prior authorization decisions, but it is not final. A new JAMA study shows why even short delays matter.
The Medicaid coverage gap still leaves many low-income adults uninsured in 2026, and the burden continues to fall disproportionately on communities of color.
CMS says 23.1 million people picked 2026 Marketplace coverage, but many moved to bronze plans that cut monthly premiums while raising deductibles and risk.
CDC says measles cases are rising in 2026. Here’s what exposure means, which symptoms come first, and when to call ahead for fast, time-sensitive advice.
Updated migraine guidance says adults in the ER should usually get evidence-backed non-opioid care first. Here is what to expect and when headache is an emergency.
WHO’s Bangladesh outbreak update shows measles is still active globally in 2026, and travel-related cases can still spark U.S. spread where vaccination is low.
Medicare has three overlapping drug-price timelines. Here is what already changed in 2026, what starts in 2027, and why the newest 15 wait until 2028.
End of content
End of content